INSUBCONTINENT EXCLUSIVE:
Manas Jaiswal of manasjaiswal.com has a buy call on Biocon Ltd
with a target price of Rs 658
The current market price of Biocon Ltd
Time period given by analyst is Intra Day when Biocon Ltd
price can reach defined target
Manas Jaiswal recommended to keep stoploss at Rs 634
Biocon Ltd., incorporated in 1978, is a largecap company with a market cap of Rs 38454.00 crore.
Biocon Ltd
key Products/Revenue Segments include Bio Pharmaceuticals which contributed Rs 2211.10 Crore to Sales Value (91.16 % of Total Sales), Other
Operating Revenue which contributed Rs 197.70 Crore to Sales Value (8.15 % of Total Sales), Waste which contributed Rs 12.50 Crore to Sales
Value (0.51 % of Total Sales) and Sale of services which contributed Rs 4.20 Crore to Sales Value (0.17 % of Total Sales)for year ending
For quarter ended 30-09-2018, company has reported a Consolidated sales of Rs 1321.00 Crore, up 17.55 % from last quarter Sales of Rs
1123.80 Crore and up 36.38 % from last year same quarter Sales of Rs 968.60 Crore Company has reported net profit after tax of Rs 378.60
Bradbury, Mr.John Shaw, Mr.Kiran Mazumdar Shaw, Mr.M Damodaran, Mr.Mary Harney, Mr.Russel Walls, Prof.Ravi Mazumdar
LLP as its auditoRs As on 30-09-2018, company has a total of 600,000,000 shares outstanding
